Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-06-23
2009-10-27
Cook, Lisa V (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C436S501000, C436S518000, C424S009100
Reexamination Certificate
active
07608406
ABSTRACT:
The present invention relates to methods for the diagnosis and evaluation of stroke and transient ischemic attacks. A variety of markers are disclosed for assembling a panel for such diagnosis and evaluation. In various aspects, the invention provides methods for early detection and differentiation of stroke types and transient ischemic attacks, for determining the prognosis of a patient presenting with stroke symptoms, and identifying a patient at risk for cerebral vasospasm. Invention methods provide rapid, sensitive and specific assays to greatly increase the number of patients that can receive beneficial stroke treatment and therapy, and reduce the costs associated with incorrect stroke diagnosis.
REFERENCES:
patent: 4447545 (1984-05-01), DeFazio et al.
patent: 4900662 (1990-02-01), Shah et al.
patent: 5202234 (1993-04-01), Shah et al.
patent: 5206140 (1993-04-01), Marder et al.
patent: 5290678 (1994-03-01), Jackowski
patent: 5294537 (1994-03-01), Batt
patent: 5350842 (1994-09-01), Norgard
patent: 5352587 (1994-10-01), Chang et al.
patent: 5382515 (1995-01-01), Shah et al.
patent: 5382522 (1995-01-01), Shah et al.
patent: 5422393 (1995-06-01), Bricker et al.
patent: 5690103 (1997-11-01), Groth et al.
patent: 5786163 (1998-07-01), Hall
patent: 5795725 (1998-08-01), Buechler et al.
patent: 5843690 (1998-12-01), Gargan
patent: 6099469 (2000-08-01), Armstrong et al.
patent: 6117744 (2000-09-01), Debold
patent: 6124430 (2000-09-01), Mischak et al.
patent: 6156521 (2000-12-01), Buechler et al.
patent: 6174686 (2001-01-01), Buechler et al.
patent: 6235489 (2001-05-01), Jackowski
patent: 6309888 (2001-10-01), Holvoet et al.
patent: 6443889 (2002-09-01), Groth et al.
patent: 6461828 (2002-10-01), Stanton et al.
patent: 6579687 (2003-06-01), Buechler et al.
patent: 6586244 (2003-07-01), Reinhard
patent: 6627404 (2003-09-01), Buechler et al.
patent: 6627457 (2003-09-01), Pandian et al.
patent: 6670138 (2003-12-01), Gonzalez-Zulueta et al.
patent: 6828107 (2004-12-01), Asada et al.
patent: 6897030 (2005-05-01), Seilhamer et al.
patent: 6939678 (2005-09-01), Buechler et al.
patent: 6991907 (2006-01-01), Buechler et al.
patent: 7341838 (2008-03-01), Buechler et al.
patent: 7358055 (2008-04-01), Valkirs et al.
patent: 7361473 (2008-04-01), Valkirs et al.
patent: 2003/0022235 (2003-01-01), Dahlen et al.
patent: 2003/0119064 (2003-06-01), Valkirs et al.
patent: 2003/0199000 (2003-10-01), Valkirs et al.
patent: 2003/0211544 (2003-11-01), Buechler et al.
patent: 2003/0219734 (2003-11-01), Buechler
patent: 2004/0072805 (2004-04-01), Warren et al.
patent: 2004/0121343 (2004-06-01), Buechler et al.
patent: 2004/0121350 (2004-06-01), Anderberg et al.
patent: 2004/0126767 (2004-07-01), Anderberg et al.
patent: 2004/0167341 (2004-08-01), Haffner et al.
patent: 2004/0171064 (2004-09-01), Dahlen et al.
patent: 2004/0176914 (2004-09-01), Buechler et al.
patent: 2004/0203083 (2004-10-01), Buechler et al.
patent: 2004/0209307 (2004-10-01), Valkirs et al.
patent: 2004/0219509 (2004-11-01), Valkirs et al.
patent: 2004/0253637 (2004-12-01), Buechler et al.
patent: 2005/0148024 (2005-07-01), Buechler
patent: 2005/0164317 (2005-07-01), Buechler et al.
patent: 2005/0181386 (2005-08-01), Diamond et al.
patent: 2006/0051825 (2006-03-01), Buechler et al.
patent: 2006/0105419 (2006-05-01), Blankenberg et al.
patent: 2007/0196880 (2007-08-01), Buechler et al.
patent: 2007/0218498 (2007-09-01), Buechler et al.
patent: 2007/0224643 (2007-09-01), McPherson et al.
patent: 2007/0269836 (2007-11-01), McPherson
patent: 2008/0045444 (2008-02-01), Whittaker
patent: 2008/0118924 (2008-05-01), Buechler
patent: 2008/0293920 (2008-11-01), Buechler
patent: WO 96/32648 (1996-10-01), None
patent: WO 98/43630 (1998-08-01), None
patent: WO 99/18442 (1999-04-01), None
patent: WO 00/18801 (2000-04-01), None
patent: WO 00/52476 (2000-09-01), None
patent: WO 01/14885 (2001-03-01), None
patent: WO 02/23191 (2002-03-01), None
patent: WO 02/083913 (2002-10-01), None
patent: WO 02/089657 (2002-11-01), None
patent: WO 02/089657 (2002-11-01), None
patent: WO 03/002553 (2003-01-01), None
patent: WO 03/002553 (2003-03-01), None
Tervaert (JN Journal of Nephrology, 1996, vol. 9, No. 5, pp. 232-240).
Cuzzocrea et al. (Brain Research, vol. 875, 2000, pp. 96-106).
Roger et al. (Journal of the American College of Cardiology, 1999, vol. 34, No. 1, pp. 155-162).
Griffin et al. (Kidney International, vol. 55, 1999, pp. 917-925).
Minota et al. (Scandinavian Journal of Rheumatology, 1999, vol. 28, pp. 94-99).
Christou et al. (Stroke, 2000, vol. 31, No. 8, pp. 1812-1816).
Kikkinos et al. (Neurologic Clinics, 1993, vol. 11, No. 3, pp. 577-590, Abstract Only).
Yakovlev et al., Activation of CPP32-Like Caspases Contributes to Neuronal Apoptosis and Neurological Dysfunction after Traumatic Brain Injury, The Journal of Neuroscience, Oct. 1, 1997, 17 (19): 7415-7424.
Huttunen et al., Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced glycation End Products (RAGE) Activation., Journ. of Biological Chem. vol. 275, Dec. 22, 2000, pp. 40096-40105.
Mussack et al., early cellular brain damage and systemic inflammatory response after cardiopulmonary resuscitation or isolated sever ehad trauma, Resuscitation, (May 2001) vol. 49, No. 2, pp. 193-199.
Interlinational Search Report and the Written Opinion of the International Searching Authority from PCT Application No. PCT/US04/12024.
Mussack et al., Early cellular brain damage and systemic inflammatory response after cardiopulmonary resuscitation or isolated severe head trauma: a comparative pilot study on common pathomechanisma. Resuscitation, 49:193-199, 2001.
Yakoviev et al., Activation of CPP32-Like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. The Journal of Neuroscience, 17(19): 7415-724, 1997.
International Search Report for international application No. PCT/US04/26984.
Notice of References Cited, PTO-892, Part of Paper No. 20041202 from U.S. Appl. No. 10/225,082, filed Aug. 20, 2002.
Harter et al., Caspase-3 activity is present in cerebrospinal fluid from patients with traumatic brain injury. Journal of Neuroimmunology, 121:76-78, 2001.
Fonarow et al., “Combining Natriuretic Peptides and Necrosis Markers in Determining Prognosis in Heart Failure,” Reviews in Cardiovascular Medicine, 2003, Suppl. 4, vol. 4.
Richards et al., “Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction,” Heart, 1999, pp. 114-120, vol. 81.
Saady et al., “Left appendage: structure function, and role in thromboembolism,” Heart, 1999, pp. 547-555, vol. 82.
Cassin et al.,Érealizzabile una strategia operative piu efficace per la gestione in urgenza del paziente con dolore toracico acuto?, Ital Heart J Suppl, Feb. 2000, pp. 186-201, vol. 1.
Futterman et al.,Novel Markers in the Acute Coronary Syndrome: BNP, IL-6, PAPP-A, American Journal of Critical Care, Mar. 2002, pp. 168-172, vol. 11, No. 2.
Hunt et al.,Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment, Clinical Endocrinology, 1997, pp. 287-296, vol. 47.
Sagnella et al.,Measurement and significance of circulating natriuretic peptides in cardiovascular disease, Clinical Science, Nov. 1998, pp. 519-529, vol. 95, No. 5.
Sonel et al., Prospective Study Correlating Fibrinopeptide A, Troponin I, Myoglobin, and Myosin Light Chain Levels with Early and Late Ischemic Events in Consecutive Patients Presenting to the Emergency Department with Chest Pain, Circulation, Sep. 5, 2000, pp. 1107-1113, vol. 102, No. 10.
Greenberg, Angiogenesis and stroke, Drug News and Perspectives, 11(5):265-270, 1998. (Abstract only).
Meester et al., In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (prodipine), Biochemical Pharmacology, 54:173-179, 1997.
Mills et al., Sustained hemodynamic effects of an Infusion of nesiritide (human b-type natriuretic peptide) in heart failure, Journal of the American college of c
Buechler Kenneth F.
Dahlen Jeffrey R.
Kirchick Howard J.
Valkirs Gunars E.
Biosite, Inc.
Cook Lisa V
Ortiz-Suarez Anavelys
Wilson Sonsini Goodrich & Rosati
LandOfFree
Diagnostic markers of stroke and cerebral injury and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic markers of stroke and cerebral injury and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic markers of stroke and cerebral injury and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4064744